International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV

Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial

(2017) Kevin J Harrington et al.   LANCET ONCOLOGY

Predictors of the course of quality of life during therapy in women with primary breast cancer

(2017) Achim Wöckel et al.   QUALITY OF LIFE RESEARCH

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

(2016) Robert L. Ferris et al.   NEW ENGLAND JOURNAL OF MEDICINE

European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Head and Neck Module, updated version: Preliminary psychometric data from Serbian laryngectomized patients

(2015) Sanja Krejovic Trivic et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

The course of psychiatric co-morbidity in patients with breast cancer - results from the prospective multi-centre BRENDA II study

(2015) Susanne Singer et al.   PSYCHO-ONCOLOGY

Measuring quality of life in patients with head and neck cancer: Update of the EORTC QLQ-H&N Module, Phase III

(2014) Susanne Singer et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research

(2013) Bryce B. Reeve et al.   QUALITY OF LIFE RESEARCH

Quality of life in patients with head and neck cancer receiving targeted or multimodal therapy - Update of the EORTC QLQ-H&N35, Phase I

(2012) Susanne Singer et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer

(2012) Arlene A. Forastiere et al.   JOURNAL OF CLINICAL ONCOLOGY

Performance of the EORTC questionnaire for the assessment of quality of life in head and neck cancer patients EORTC QLQ-H&N35: a methodological review

(2012) Susanne Singer et al.   QUALITY OF LIFE RESEARCH

Rare cancers of the head and neck area in Europe

(2011) B.A.C. Van Dijk et al.   EUROPEAN JOURNAL OF CANCER

PD28. Induction chemotherapy (ICT) and sequential therapy (ST) in locoregionally advanced head and neck cancer

(2011) Jan B. Vermorken   ORAL ONCOLOGY

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

(2009) James A Bonner et al.   LANCET ONCOLOGY

Content comparison of quality of life questionnaires used in head and neck cancer based on the international classification of functioning, disability and health: a systematic review

(2008) U. Tschiesner et al.   EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY

Quality of life during first-line palliative chemotherapy for recurrent and metastatic head and neck cancer with weekly cisplatin and docetaxel

(2008) Orlando Guntinas-Lichius et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY